Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma

This publication has 16 references indexed in Scilit:

• An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer
  The Annals of Thoracic Surgery, 2002
• PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma
  European Journal of Cardio-Thoracic Surgery, 2001
• POSITRON EMISSION TOMOGRAPHY
  Radiologic Clinics of North America, 2001
• Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass Lesions
  JAMA, 2001
• The usefulness of positron emission tomography in evaluating patients for pulmonary malignancies.
  Chest, 2000
• Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results
  European Journal of Nuclear Medicine and Molecular Imaging, 2000
• Factors associated with false-positive staging of lung cancer by positron emission tomography
  The Annals of Thoracic Surgery, 2000
• Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission Tomography
  New England Journal of Medicine, 2000
• How Useful is Positron Emission Tomography for Lymphnode Staging in Non-Small-Cell Lung Cancer?
  The Thoracic and Cardiovascular Surgeon, 2000
• Imaging of mediastinal lymph nodes: CT, MR, and FDG PET.
  RadioGraphics, 1998